Browsing by Author Franco Fernández, Rafael

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 95 to 114 of 130 < previous   next >
Issue DateTitleAuthor(s)
Dec-2011Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's diseaseArmentero, Marie Therese; Pinna, Annalisa; Ferré, Sergi; Lanciego, José Luis; Müller, Christa E.; Franco Fernández, Rafael
15-Aug-2013Phenyl acyl acids attenuate the unfolded protein response in tunicamycin-treated neuroblastoma cells.Zamarbide, Marta; Martínez-Pinilla, Eva; Ricobaraza, Ana; Aragón, Tomás; Franco Fernández, Rafael; Pérez-Mediavilla, Alberto
26-Apr-2023Potencial dels heteròmers de receptors d'adenosina i de cannabinoides com a dianes terapèutiques en malalties neurodegeneratives i obesitatLillo Márquez, Alejandro
30-Sep-2014Potential of caveolae in the therapy of cardiovascular and neurological diseases.Navarro Brugal, Gemma; Borroto Escuela, Dasiel Oscar; Fuxe, Kjell; Franco Fernández, Rafael
15-Feb-2006Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromersCiruela Alférez, Francisco; Casadó, Vicent; Rodrigues Sepúlveda Marques, Ricardo Jorge; Luján, Rafael; Burgueño, Javier; Canals, Meritxell; Borycz, Janusz; Rebola, Nelson; Goldberg, Steven R.; Mallol Montero, Josefa; Cortés Tejedor, Antonio; Canela Campos, Enric I.; López-Giménez, Juan F.; Milligan, Graeme; Lluís i Biset, Carme; Cunha, Rodrigo A.; Ferré, Sergi; Franco Fernández, Rafael
5-Apr-2016Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and GsNavarro Brugal, Gemma; Cordomí, Arnau; Zelman-Femiak, Monika; Brugarolas Campillos, Marc; Moreno Guillén, Estefanía; Aguinaga Andrés, David; Pérez-Benito, Laura; Cortés Tejedor, Antonio; Casadó, Vicent; Mallol Montero, Josefa; Canela Campos, Enric I.; Lluís i Biset, Carme; Pardo, Leonardo; García-Saez, Ana J.; McCormick, Peter J.; Franco Fernández, Rafael
4-Apr-2021Qué es el estrés oxidativo y cómo afecta al envejecimientoFranco Fernández, Rafael
2011Real-time G-protein-coupled receptor imaging to understand and quantify receptor dynamicsAymerich, Maria S.; López-Azcárate, Jon; Bonaventura, Jordi; Navarro Brugal, Gemma; Fernández-Suárez, D.; Casadó, Vicent; Mayor, Federico; Lluís i Biset, Carme; Valencia, Miguel; Artieda, Julio; Franco Fernández, Rafael
6-Jul-2012Receptores de dopamina y heterómeros de receptores de dopamina en la modulación de la neurotransmisiónGonzález González, Sergio
26-Aug-2022Regulation of Expression of Cannabinoid CB2 and Serotonin 5HT1A Receptor Complexes by Cannabinoids in Animal Models of Hypoxia and in Oxygen/Glucose-Deprived NeuronsLillo, Jaume; Raïch, Iu; Silva, Laura; Zafra, David A.; Lillo, Alejandro; Ferreiro-Vera, Carlos; Sánchez de Medina, Verónica; Martínez-Orgado, José; Franco Fernández, Rafael; Navarro Brugal, Gemma
Jul-2011Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonistJustinová, Zuzana; Ferré, Sergi; Redhi, Godfrey H.; Mascia, Paola; Stroik, Jessica; Quarta, Davide; Yasar, Sevil; Müller, Christa E.; Franco Fernández, Rafael; Goldberg, Steven R.
14-Sep-2018Relevant Molecular and Functional G.Protein Coupled Receptor Interactions in Neuroinflammation and Addiction = Interaccions moleculars i funcionals de receptors acoblats a proteïna G rellevants en neuroinflamació i addicióAngelats Canals, Edgar
22-May-2022Robustness of the Krebs Cycle under Physiological Conditions and in Cancer: New Clues for Evaluating Metabolism-Modifying Drug TherapiesFranco Fernández, Rafael; Serrano-Marín, Joan
7-Nov-2021Similarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors.Raïch, Iu; Rivas‐Santisteban, Rafael; Lillo, Alejandro; Lillo, Jaume; Reyes Resina, Irene; Nadal, Xavier; Ferreiro-Vera, Carlos; Sánchez de Medina, Verónica; Majellaro, Maria; Sotelo, Eddy; Navarro Brugal, Gemma; Franco Fernández, Rafael
15-Dec-2019Specificity and nanomolar potency of melatonin on G-protein coupled melatonin MT1 and MT2 receptors expressed in HEK-293T human embryo kidney cellsRivas‐Santisteban, Rafael; Reyes Resina, Irene; Raïch, Iu; Pintor, Jesus J.; Alkozi, Hanan Awad; Navarro Brugal, Gemma; Franco Fernández, Rafael
2011Striatal pre- and postsynaptic profile of adenosine A2A receptor antagonistsOrrù, Marco; Bakešová, Jana; Brugarolas Campillos, Marc; Quiroz, César; Beaumont, Vahri; Goldberg, Steven R.; Lluís i Biset, Carme; Cortés Tejedor, Antonio; Franco Fernández, Rafael; Casadó, Vicent; Canela Campos, Enric I.; Ferré, Sergi
25-Jun-2014Successful therapies for Alzheimer's disease: why so many in animal models and none in humans?Franco Fernández, Rafael; Cedazo-Mínguez, Ángel
6-Oct-2015Suggesting a Way to Understand the Actual Potential of Anti-Alzheimer's Disease Drugs That Show Promise in Transgenic Mouse Models.Franco Fernández, Rafael; Petrovic, Milos
2002Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: Implications for striatal neuronal function.Ferré, Sergi; Karcz-Kubicha, Marzena; Hope, Bruce T.; Popoli, Patrizia P.; Burgueño, Javier; Gutierrez, Angeles M.; Casadó, Vicent; Fuxe, Kjell; Goldberg, Steven R. G; Lluís, Carme; Franco Fernández, Rafael; Ciruela Alférez, Francisco
22-Jul-2022Targeted Metabolomics Shows That the Level of Glutamine, Kynurenine, Acyl-Carnitines and Lysophosphatidylcholines Is Significantly Increased in the Aqueous Humor of Glaucoma Patients.Lillo, Alejandro; Marín Martínez, Silvia; Serrano-Marín, Joan; Binetti, Nicolas; Navarro Brugal, Gemma; Cascante i Serratosa, Marta; Sánchez-Navés, Juan; Franco Fernández, Rafael